Your browser doesn't support javascript.
loading
Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik, Tobias; Schwalbe, Edward C; Hicks, Debbie; Smith, Amanda; Zur Muehlen, Anja; Figarella-Branger, Dominique; Doz, François; Rutkowski, Stefan; Lannering, Birgitta; Pietsch, Torsten; Clifford, Steven C.
Afiliación
  • Goschzik T; Department of Neuropathology, DGNN Brain Tumour Reference Center, University of Bonn Medical Center, Bonn, Germany.
  • Schwalbe EC; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Department of Applied Sciences, Northumbria University, Newcastle upon Tyne, UK.
  • Hicks D; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Smith A; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Zur Muehlen A; Department of Neuropathology, DGNN Brain Tumour Reference Center, University of Bonn Medical Center, Bonn, Germany.
  • Figarella-Branger D; Department of Pathology and Neuropathology, Assistance Publique Hôpitaux de Marseille, and Institute of Neurophysiopathology, UMR CNRS 7051 Aix Marseille University, Marseille, France.
  • Doz F; SIREDO Cancer Center (Care, Innovation and Research in Pediatric, Adolescents and Young Adults Oncology), Institut Curie and University Paris Descartes, Paris, France.
  • Rutkowski S; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Lannering B; Department of Pediatrics, University of Gothenburg and the Queen Silvia Children's Hospital, Gothenburg, Sweden.
  • Pietsch T; Department of Neuropathology, DGNN Brain Tumour Reference Center, University of Bonn Medical Center, Bonn, Germany.
  • Clifford SC; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK. Electronic address: steve.clifford@ncl.ac.uk.
Lancet Oncol ; 19(12): 1602-1616, 2018 12.
Article en En | MEDLINE | ID: mdl-30392813
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Neoplasias Cerebelosas / Aberraciones Cromosómicas / Cromosomas Humanos / Técnicas de Diagnóstico Molecular / Meduloblastoma Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Neoplasias Cerebelosas / Aberraciones Cromosómicas / Cromosomas Humanos / Técnicas de Diagnóstico Molecular / Meduloblastoma Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Alemania